Submission of Matters to a Vote of Security Holders
→
11/18/25
Exec Change
Departure or Appointment of Directors or Certain Officers
→
11/17/25
Other
Other Events
→
9/2/25
Reg FD
Regulation FD Disclosure
→
8/11/25
Exec Change
Entry into a Material Definitive Agreement
→
↓
Prospectuses & Registrations
29 shown
Filed
Form
Description
3/2/26
S-8
S-8
→
11/10/25
ARS
ARS
→
3/5/25
S-8
S-8
→
3/5/25
S-8
S-8
→
10/29/24
ARS
ARS
→
8/2/24
424B5
424B5
→
↓
Filing History(310 filings)
TypeDateAccessionPeriodSize
144
Mar 6, 2026
0001193125-26-097240
—
6.9 KB
S-8
Mar 2, 2026
0001193125-26-084183S-8
—
249.0 KB
8-K
Mar 2, 2026
0001193125-26-0840828-K
Mar 2, 2026
203.8 KB
10-K
Mar 2, 2026
0001937653-26-00001510-K
Dec 31, 2025
15.6 MB
8-K
Mar 2, 2026
0001937653-26-0000138-K
Mar 2, 2026
342.6 KB
144
Feb 17, 2026
0001193125-26-055609
—
5.5 KB
144
Feb 13, 2026
0001193125-26-052127
—
5.8 KB
SCHEDULE 13G/A
Feb 13, 2026
0001104659-26-015252
—
10.3 KB
SCHEDULE 13G/A
Feb 12, 2026
0000895421-26-000053
—
7.9 KB
3
Feb 2, 2026
0001193125-26-0341003
Feb 1, 2026
18.9 KB
4
Jan 13, 2026
0001193125-26-0118854
Jan 12, 2026
16.9 KB
3
Jan 13, 2026
0001193125-26-0118753
Jan 9, 2026
23.0 KB
4
Jan 13, 2026
0001193125-26-0117934
Jan 12, 2026
7.3 KB
3
Jan 13, 2026
0001193125-26-0117543
Jan 12, 2026
13.7 KB
4
Jan 12, 2026
0001193125-26-0108654
Jan 12, 2026
9.2 KB
4
Jan 12, 2026
0001193125-26-0108644
Jan 12, 2026
7.3 KB
4
Jan 12, 2026
0001193125-26-0108604
Jan 12, 2026
7.3 KB
4
Jan 12, 2026
0001193125-26-0108594
Jan 12, 2026
7.3 KB
4
Jan 12, 2026
0001193125-26-0108564
Jan 12, 2026
7.3 KB
4
Jan 12, 2026
0001193125-26-0108524
Jan 12, 2026
7.3 KB
4
Jan 12, 2026
0001193125-26-0108434
Jan 12, 2026
7.3 KB
4
Jan 12, 2026
0001193125-26-0108344
Jan 12, 2026
16.8 KB
4
Jan 12, 2026
0001193125-26-0107904
Jan 12, 2026
16.8 KB
144
Jan 12, 2026
0001193125-26-010578
—
4.4 KB
144
Jan 12, 2026
0001193125-26-010577
—
5.1 KB
25 filings shown
Zymeworks Inc. — SlamSEC
Proxies
8 shown
Filed
Form
Description
11/10/25
DEFA14A
DEFA14A
→
11/10/25
DEF 14A
DEF 14A
→
10/29/24
DEFA14A
DEFA14A
→
10/29/24
DEF 14A
DEF 14A
→
10/26/23
DEFA14A
DEFA14A
→
10/26/23
DEF 14A
DEF 14A
→
↓
Ownership
40 shown
Filed
Form
Description
2/2/26
3
3
→
1/13/26
4
4
→
1/13/26
3
3
→
1/13/26
4
4
→
1/13/26
3
3
→
1/12/26
4
4
→
↓
Other Filings
40 shown
Filed
Form
Description
3/6/26
144
144
→
2/17/26
144
144
→
2/13/26
144
144
→
2/13/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
2/12/26
SCHEDULE 13G/A
SCHEDULE 13G/A
→
1/12/26
144
144
→
↓
Zymeworks Inc. is a publicly held biotechnology company based in Vancouver,
British Columbia, that develops protein therapeutics for the treatment of cancer as well as for autoimmune and inflammatory diseases.